Drugs that contain Hydralazine Hydrochloride; Isosorbide Dinitrate
1. Bidil patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6465463 | AZURITY | Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
Sep, 2020
(3 years ago) | |
| US6784177 | AZURITY | Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
Sep, 2020
(3 years ago) | |
Market Authorisation Date: 23 June, 2005
Treatment: Method of treatment of heart failure
Dosage: TABLET;ORAL
More Information on Dosage
BIDIL family patents
